PRESS RELEASEOMass Therapeutics appoints Birgitte Volck as Non-Executive DirectorOxford, United Kingdom – 26 February 2025 – ...
There is no escaping from the fact that the British company has proved perennially disappointing for investors. Around £10bn ...
The Financial Times and data provider Statista are publishing the first UK’s Best Employers ranking, which lists 500 ...
On appointment, Dr Screaton will become a member of the GSK Board Science Committee and the Corporate Responsibility ...
London stocks closed with little direction on Friday as investors weighed fresh economic data, including signs of slowing ...
London stocks had nudged higher by midday on Friday as investors digested a raft of UK data releases, while Standard ...
GSK’s share price has fallen a long way on a combination of factors, but do its recent strong results leave its current price looking cheap to me?
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved PENMENVY (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...
GSK’s MenABCWY vaccine is an injectable suspension intended for intramuscular use. It comes with a vial of lyophilised ...
However, Dr Raza said "awful" electricity costs could stunt growth and said the government should invest in renewable energy ...
GSK, the tenth biggest pharmaceutical company in the world, is investing £50 million to establish the GSK–Oxford Cancer Immuno-Prevention Programme, aimed at advancing the development of a ...